Pharmacists in Sullivan, IL Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Andrew Hardiek Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 208 W Jackson St, Sullivan, IL 61951 Phone: 217-728-7216 |
 Dr. Cindi L Reed, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17 N Hamilton St, Sullivan, IL 61951 Phone: 217-273-0133 |
Dr. Michael Russell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 208 W Jackson St, Sullivan, IL 61951 Phone: 217-728-7216 Fax: 217-728-2816 |
Dr. Tyler Jacob Alberson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 208 W Jackson St, Sullivan, IL 61951 Phone: 217-728-7216 Fax: 217-728-2816 |
News Archive
Friday opinions: Mandate to buy insurance; Medicare and 'political game'
If Americans want a private health insurance system that does not base the price of individually sold policies on that individual's health status and that does not allow an insurer to refuse to sell a policy because of an individual's health issues, then they should accept a mandate that all Americans purchase at least a minimum package of health insurance (Uwe Reinhardt, 6/25).
Peritonitis commonly arises in the weeks before many dialysis patients die
An infection called peritonitis commonly arises in the weeks before many dialysis patients die, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
Insight into how mutations in LRRK2 gene may cause familial Parkinson's disease
Using new one-of-a-kind "mouse models" that promise to have a significant impact on future Parkinson's disease research, Mount Sinai School of Medicine researchers are among the first to discover how mutations in a gene called LRRK2 may cause inherited (or "familial") Parkinson's disease, the most common form of the disease. The study, published in The Journal of Neuroscience, is the first in vivo evidence that LRRK2 regulates dopamine transmission and controls motor performance, and that the mutation of LRRK2 eliminates the normal function of LRRK2, leading to Parkinson's disease.
Sepracor to change name to Sunovion Pharmaceuticals
Sepracor Inc. and Dainippon Sumitomo Pharma Co., Ltd., an Osaka, Japan-based pharmaceutical company, announced today the intent to change the Sepracor name to Sunovion Pharmaceuticals Inc. in the United States. DSP acquired Sepracor in October 2009 and the name change is planned to occur in anticipation of the one-year anniversary of the acquisition. Sepracor intends to begin officially operating as Sunovion Pharmaceuticals Inc. before the end of 2010.
Precision cancer drugs spark powerful immune response and boost effects of immunotherapy
Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.
› Verified 9 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Occupational Therapists